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Background: The glycoprotein D (gD) is essential for Herpes B virus (BV) entry into
mammalian cells. Nectin-1, an HSV-1 gD receptor, is found to be the receptor which
mediated BV induced cell-cell fusion, while HVEM does not mediate fusion by BV
glycoprotein. However, the specific sequence and structural requirements of the BV
gD for the recognition of and binding to Nectin-1 are unknown. Moreover, the 3D
structures of BV gD and the BV gD-receptor complex have not been determined. In
this study, we propose a reliable model of the interaction of the BV gD with receptor
using bioinformatics tools.
Results: The three-dimensional structures of two BV gD-receptor complexes were
constructed using homology modelling and docking strategy. Based on the models
of these complexes, the BV gD receptor interaction patterns were calculated. The
results showed that the interface between the BV gD and nectin-1 molecule is not
geometrically complementary. The computed molecular interactions indicated that
two terminal extensions were the main region of BV gD that binds to nectin-1 and that
hydrophobic contacts between the two molecules play key roles in their recognition
and binding. The constructed BV gD-HVEM complex model showed that this complex
had a lower shape complementarity value and a smaller interface area compared with
the HSV-1 gD-HVEM complex, and the number of intermolecular interactions between
BV gD-HVEM were fewer than that of HSV-1 gD-HVEM complex. These results could
explain why HVEM does not function as a receptor for BV gD.
Conclusion: In this study, we present structural model for the BV gD in a complex with
its receptor. Some features predicted by this model can explain previously reported
experimental data. This complex model may lead to a better understanding of the
function of BV gD and its interaction with receptor and will improve our understanding
of the activation of the BV fusion and entry process.
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Herpes B virus (BV) is a member of genus Simplexvirus within the Alphaherpesvirinae
subfamily. It has also been known as Cercopithecine herpes virus 1, monkey B virus, B
virus or Herpes B Monkey virus [1]. BV naturally infects macaque monkeys and gener-
ally causes only mild localized or asymptomatic infections [2]. When transmitted to
foreign hosts, such as humans or monkey species other than macaques, B virus often
results in severe pathogenesis, including paralysis, encephalitis, encephalomyelitis, and© 2014 Li et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
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infection cases [6].
Because of the high mortality of its infection in untreated humans and the lack of
vaccines, BV is classified as a biosafety level 4 (BSL-4) pathogen [7,8]. Owing to the
biosafety concerns, little research has been conducted directly using BV; most of the
knowledge on this virus is extrapolated from study of its closely related viral species of
the subfamily Alphaherpesvirinae, herpes simplex virus (HSV) type 1 (HSV-1) and
HSV-2 [6].
BV has been shown to display many similar biological characteristics with HSV-1 and
HSV-2 [9-11]. The genomes of BV and HSV-1 and HSV-2 are made up by homologous
genes in the same order and orientation [2,12,13]. The similarity is at an average of ap-
proximately 62% identity of amino acid residues for all homologous proteins of herpes
B shares with HSV-1 and HSV-2. In its natural host, B virus exhibits similar signs of in-
fection to that observed on HSV infections in humans. Similarly to the high pathogen-
icity of BV in humans, HSV infection of marmosets can also be fatal [14].
HSV entry into target cells occurs primarily through the interactions of viral envelope
glycoproteins with a variety of cellular receptors. There are 11 known enveloped pro-
teins on the virus surface of HSV-1 and a minimum four of them are believed to be in-
volved in HSV entry and fusion. Among them, glycoprotein D (gD) is believed to have
an important role for virus entry into mammalian cells.
It is widely accepted that binding of HSV-1 gD to a cell surface receptor triggers the
conformational changes in other viral glycoproteins leading to membrane fusion and viral
entry [15,16]. Up to now, at least four HSV receptors have been identified: herpesvirus
entry mediator (HVEM), nectin-1, nectin-2, and 3-O-sulfated heparan sulfate [17-20].
A previous study shows that nectin-1 mediates fusion of cells expressing glycoprotein
from BV while HVEM does not mediate fusion by BV glycoprotein [21]. In other
words, nectin-1 is the “master” receptor for B virus infection [22].
To further establish the molecular basis of BV fusion to the host cell, a structural
view of the interaction between gD and nectin-1 should be obtained. Although no
structural information on BV gD has not been reported, the previously reported struc-
tures of HSV-1 gD alone and bound to nectin-1 provide an opportunity to propose a
structural model for BV gD-receptor complex.
The aim of this study is to define a structural model for the BV gD-nectin-1 complex
and to describe the interaction between BV gD and nectin-1 using computational
methods. Therefore, we can identify and characterise the binding region within BV gD
that binds to its surface receptor and understand required interactions between the
glycoprotein and its receptor critical for virus fusion and entry.Results
Homology modeling of BV gD
Up to now, there is no structural information on either BV gD or the BV gD-receptor
complex. The purpose of this study is to model the structural features of BV gD
that interact with its receptor. As the first step, the three dimensional structure of
BV gD should be modeled. The template identification was performed by a BLAST
search against PDB. Among the BLAST hits, its ortholog in HSV-1 shows the highest
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apo and receptor bound form had been solved [15,23,24]. The sequence identities be-
tween HSV-1 gD and BV gD are up to 62%. The sequence alignment of HSV-1 gD and
BV gD is shown in Figure 1. The asterisk represents identical amino acids present in
two protein sequences.
In total, 3D model of BV gD was generated using the structure of HSV-1 gD with
MODELER. The templates selected for homology modeling was the HSV-1 gD crystal
structure in nectin-1 binding form (PDB code 3U82). The structure of BV gD was
similar to that of HSV-1 gD, with an r.m.s. deviation of 2.34 Å for 231 Cα positions
(residues 24–254). In the predicted BV gD structure (Figure 2), the central Ig-like V
domain (residues 57–185) is comprised of nine strands, and flanked by the N- and C-
terminal extensions. The N-terminal extension (residues 24 to 56) of gD forms a hair-
pin structure. The C-terminal extension (residues 186 to 254) includes four helices
and few loops. The two terminal extensions constitute a big, flat surface.
The quality of the predicted BV gD structure was evaluated using the Profiles-3D
[25] and Ramachandran Plot method [26] in Discovery Studio 2.5 (Accelrys Inc.). The
two protocols validate a protein model by performing full geometric analysis as well as
stereo chemical quality of a protein structure. The Profiles-3D checks the validity of a
protein structure by measuring the compatibility of a 3D structure with the sequence
of the protein. This is a useful measure of the overall quality of the structure. The
Ramachandran plot provides an easy way to view the distribution of torsion angles of a
protein structure. The two torsion angles of a polypeptide chain describe the rotations
of the polypeptide backbone around the bonds between N-Cα and Cα-C, which are
among the most important local structural parameters that control protein folding. TheFigure 1 Sequence alignment result of BV gD with the template HSV-1 gD. “*” represents identical
amino acids, “:” represents strong similarity, “.” represents weaker similarity, and blank represents different
amino acids or gap.
Figure 2 Ramachandran plot of the structure of BV gD.
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dimensional structures by providing an overview of allowed and disallowed regions of
torsion angle values.
According to the result from Ramachandran Plot, 91.2% residues of the predicted BV
gD model were located in the favored region, 8.3% in the additional allowed region,
0.5% in the generously allowed region and no non-Gly residues were found in the disal-
lowed region (Figure 3). The Profiles-3D program gives the similar result. The Profiles-
3D Score of this predicted BV gD model is 92.0, which is higher than the Verify
Expected Low Score (47.2). This suggests that overall quality of the model as a whole is
largely correct.
Therefore, the Profiles-3D and Ramachandran Plot results indicate that the predicted
BV gD model can be considered of good quality and employed for further analyses.The binding region of BV gD to its human receptor
Herpes B virus entry into target cells requires virus encoded glycoprotein interact with
cellular receptors to facilitate virus entry. A previous study reported that Herpes B
Virus only utilized human nectin-1 but not HVEM for cell-cell fusion and virus entry
by BV glycoprotein D [21,22]. To identify and characterize the binding region within
Figure 3 The BV gD structure obtained by homology modelling method. The structure of BV gD is
shown in carton; The N-terminal extension (residues 24 to 56) is colored green, the C-terminal extension
(residues 186 to 254) is colored yellow, and the central Ig-like V domain is colored magenta.
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for receptor binding, we constructed the BV gD-nectin-1 complex model using compu-
tational methods.
The predicted BV gD-nectin-1 complex has a shape complementarity (SC) value of
0.53, which is slightly higher than the value seen in the HSV-1 gD-nectin-1 complex
(0.44). These values are lower than those typically seen in protein receptor-ligand com-
plexes, which have the common shape complementarity values within the range of 0.62
to 0.69 [27]. This indicates that the interfaces between nectin-1 and the two gD mole-
cules are of low degree of geometrically complementarity.
The interface area of the modeled BV gD-nectin-1 complex had a value about
1646 Å2, suggesting that the complex had the “standard-size” interface observed in
other protein/protein complexes and viral glycoprotein/receptor complexes [24,28-31].
The interface area contributed by the non-polar atom was 984 Å2, which was 59.8% of
the total interface area, which hints that the hydrophobic contacts between BV gD and
nectin-1 play key roles in their recognition and binding.
A detailed analysis of the interactions between the BV gD and nectin-1 shows their
binding sites. The residues involved in the protein-protein interface of the BV gD-
nectin-1 complex were determined on the basis of the buried surface area. There were
about 25 residues in gD and 29 residues in nectin-1 that lost their accessible surface in
the complex. In the complex structure, the BV gD forms extensive interactions with
nectin-1, including 4 hydrogen bonds (Table 1), 1 salt bridge (Table 2), and 48 hydro-
phobic contacts (Table 3).
Table 1 Hydrogen bond interactions observed in the complex between BV gD- human
nectin-1 complex
Donor atom Acceptor atom Distance Angle XDA Angle DAY
NECTIN-1:Glu64:NE2 BV gD:Pro222:O 2.93 92.97 123.59
BV gD:Arg223:NH2 NECTIN-1:Glu125:OE1 2.75 113.59 129.92
NECTIN-1:Asn77:ND2 BV gD:Asp216:O 2.56 100.66 114.01
NECTIN-1:Asn77:N BV gD:Asp216:O 2.55 100.17 157.59
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tion on the interacting interface than the nectin-1 in their binding. The receptor bind-
ing sites of BV gD consists of 4 discontinuous segments, including residues 24–27, 35–
39 of the N-terminal extension and residues 216–224 and 231–235 the C-terminal ex-
tension (Figure 4). The four loops form a large, flat surface to accommodate interacting
residues of nectin-1. Among the 25 residues of BV gD, residues 38Tyr, 216Asp, 223Arg,
224Phe, were important for nectin-1 interaction, and they established more direct and
closer contact with the CpG ODN molecule. Residues 38Tyr, 235Tyr and 224Phe form
four hydrophobic interactions with nectin-1, respectively. Residues 216Asp forms two
hydrogen bonds with Asn78 in nectin-1.In particular, 223Arg forms a salt bridge with
and a hydrogen bond with Glu126 in nectin-1. The salt bridge between 223Arg and
residue Glu126 in nectin-1 was also observed in HSV-1 gD-nectin-1 complex [23]. It
could be inferred that the above residues have significant interactions with the receptor,
leading to a significant enhancement for binding. Inhibitors targeting to those residues
may even block receptor nectin-1.
The ectodomain of nectin-1 consists of three Ig domains, an N-terminal variable-like
domain (V domain) followed by two constant-like domains (C1 and C2 domain). The
interaction pattern of BV gD-nectin-1 complex showed that the BV gD interaction sites
were located at the V domain of nectin-1. Nectin-1 interacts gD mainly through five
strands and some loops connecting them. The five strands belong to a β-sheet. Among
the all, some residues, such as Asn77, Leu90, Glu125, etc., gave more interactions to
BV gD molecule.The interaction of BV gD with the receptor of its natural host
BV is a natural pathogen of monkeys. It has been shown that BV can use simian
nectin-1 for entry. To give a picture of how BV interacts with its natural host, we con-
structed a BV-gD simian nectin-1 complex model based on the human nectin-1 and
HSV-gD complex.
The pattern of BV-gD interaction with simian nectin-1(Figure 5) exhibited strong
similarities to and slight differences with that of BV-gD with human nectin-1. The pre-
dicted BV-gD simian nectin-1 interface buries 1619 Å2 of solvent-accessible surface
and has a shape complementarity value of 0.54, both values are almost identical to
those of BV-gD human nectin-1.Table 2 Salt bridge observed in the complex between BV gD- human nectin-1 complex
BV gD residue Nectin-1 residue
Arg223 Glu125
Table 3 Hydrophobic interactions observed in the complex between BV gD- human
nectin-1 complex

















There are a total of 48 hydrophobic contacts. Numbers in parentheses refer to the number of hydrophobic contacts.
Figure 4 The structure of BV gD-human nectin-1 complex. Both the BV gD and human nectin-1 are
shown in carton. The helical residues of nectin-1 are colored red, and beta sheet residues are coloured yellow,
and the loop and unassigned residues are coloured green. BV gD is coloured magenta.
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Figure 5 The structure of BV gD-monkey nectin-1complex. BV gD is colored orange, and monkey
nectin-1 is colored green. The 3-amino acid insertion in monkey nectin-1 is highlighted in magenta and
shown as sticks.
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modelled BV-gD simian nectin-1 complex. The hydrogen bonds and hydrophobic inter-
actions in this complex model are listed in Tables 4 and 5, respectively.
Nectin-1 is highly conserved among mammalian species. Monkey nectin-1 extracellular
domain amino acid sequence is 98% identical to that of human nectin-1 with 2 amino acid
substitutions and a 3-amino acid insertion after residue Lys-69 of the human nectin-1 V
domain [32]. The 3-amino acid insertion in monkey nectin-1 falls within an extended re-
gion between two beta strands and is outside of the predicted gD-binding region.
The small changes in the intermolecular interactions of the two complexes are likely
caused by the 3-amino acid insertion in monkey nectin-1 sequence. Although the 3-
amino acid insertion does not directly interact with BV gD molecule, it is located in the
loop region that connected two strands, which are constituting part of the ligand-
binding region of nectin-1. Insertions at this loop might affect the interaction of the
nearby strands, altering the shape of the nectin-1 interface. This alteration in binding
surface would affect ligand binding. Similar phenomena had been observed in other
protein complex [33,34].Table 4 Hydrogen bond interactions observed in the complex between BV gD- monkey
nectin-1 complex
Donor atom Acceptor atom Distance Angle XDA Angle DAY
Nectin-1:Gln64:NE2 BV gD:Pro222:O 3.04 65.30 129.98
Nectin-1:Asn80:N BV gD:Asp216:O 2.47 108.92 155.88
Nectin-1:Asn80:ND2 BV gD:Met220:O 3.08 158.26 109.72
BV gD:Tyr38:OH Nectin-1:Gly89:O 3.07 118.93 129.15
BV gD:Arg223:NH2 Nectin-1:Glu128:OE2 2.91 120.46 134.88
Table 5 Hydrophobic interactions observed in the complex between BV gD- monkey
nectin-1 complex
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A previous study reported that only nectin-1 is the primary receptor that mediates cell-
cell fusion and virus entry for BV and HVEM does not function as entry receptor for
BV [21,22]. To understand why HVEM does not mediate cell fusion by BV gD, we con-
structed a “hypothetical” BV gD-HVEM complex model and then compared the struc-
ture of this complex with that of HSV-1 gD-HVEM complex, and analyzed the changes
in the intermolecular interactions of the two complexes.
The overall structure of the constructed hypothetical BV gD-HVEM complex is
shown in Figure 6. It has a very low shape complementarity factor of only SC = 0.32,
which is markedly smaller than the value observed in the HSV-1 gD-HVEM complex
(SC = 0.76).
The difference in shape complementarity correlates with buried surface decrease in
the hypothetical BV gD-HVEM complex, which drops from 1432 Å2 for HSV-1 gD-
HVEM to 877 Å2 for the hypothetical BV gD-HVEM complex. The two indices have
previously been used to evaluate the extent of packing in interacting macromolecules
[35]. The SC value measures the correlation between the shapes of the interacting sur-
faces, whereas the size of interface area reflects the extent of the contact between two
molecules [36,37].
The small size of the buried surface and low SC value indicate that the interaction be-
tween BV gD and HVEM is weak. In the predicted BV gD-HVEM model, only a few
intermolecular interactions were found, including 2 hydrogen bonds and 17 hydropho-
bic contacts (Table 6). The two figures are significantly smaller than those observed in
HSV-1 gD-HVEM complex (Table 7). The lessening in intermolecular interactions
greatly decreases the binding stability. It can be deduced that BV gD and HEVM be not
able to form a stable complex because of the bad binding affinity between them.
Extensive mutagenic analysis of HSV-1 gD has been performed [38]. It has been
found that amino acid substitutions on gD may abrogate physical and functional inter-
actions of gD with HVEM. The inability of gD mutants to bind HVEM may have two
Figure 6 The “hypothetical” BV gD-HVEM complex model. The HVEM is colored red. The N-terminal
extension of BV gD is colored green, the C-terminal extension and the central V domain are colored magenta.
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the mutation may prevent proper formation of the hairpin.
It has been noted that Leu25 and Gln27 are critical for gD to form a the N terminal
hairpin conformation [38]. Point mutations at position 25 and/or 27 are sufficient to
abrogate HVEM binding, possibly because of poor formation of the hairpin [39,40].
Sequence analysis revealed that the BV gD and HSV-1 gD sequences share the same
amino acid residues at position 25 and 27 (Figure 1). Based on the above observation, it
can be inferred that BV-gD has the ability to form a N-terminal hairpin conformation.
In fact, in our constructed BV gD-HVEM model, BV-gD N-terminus adopts a hairpin
structure (Figure 6).
To gain insights into the sequence changes that contribute to the bad affinity of BV
gD with HVEM, we undertook a comprehensive evaluation of the energetic contribu-
tions of all the residues in the HVEM binding interface of the HSV-1 gD. All positions
that have different residues in BV-gD and HSV-1 gD within the HEAM binding inter-
face were considered. According to sequence comparison, BV gD and HSV-1 gD differTable 6 Intermolecular hydrogen bond interactions observed in the “hypothetical” BV
gD-HVEM complex
Donor atom Acceptor atom Distance Angle XDA Angle DAY
BV gD:Arg11:NH1 HVEM:Cys37:O 2.78 83.98 95.04
BV gD:Arg11:NH2 HVEM:Cys37:O 2.84 81.55 70.25
Table 7 gD-HVEM interfaces
Ligand Receptor Interface area (Å2) SC H-bonds Hydrophobic contacts
HSV-1 gD HVEM 1431.357 0.757 10 25
BV gD HVEM 877.726 0.316 2 17
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of HSV-1 gD mutants and HVEM were estimated with the FoldX program. The HSV-1
gD mutants were focused on the 15 positions which have different residue with BV gD,
and each position was mutated to the corresponding residue at the equivalent position
of BV gD.
The absolute values of the free energies are meaningless since the FoldX forcefield is
not scaled to fit the real free energy, but the relative difference between calculations is
meaningful. The difference in the binding energies of the mutant and wild type struc-
tures can be used to estimate the effect of the amino acid variation on the stability of
the protein-protein interaction. The predicted binding free energies of mutant HSV-1
gD-HVEM complexes were compared with the WT complex. The results are presented
in Table 8. According to the calculation, the binding free energies for most substitu-
tions compared with the WT complex were positive, these results implicate that most
substitutions from HSV-1 gD residues to BV gD ones are likely to diminish the binding
of HSV-1 gD with HVEM.Discussion
It is believed that the binding of BV gD to a cell surface receptor leads to membrane fu-
sion and viral entry. Nectin-1 is known to be the “master” receptor for B virus infection.Table 8 Changes in binding free energies between HSV-1 gD - HEVM complex resulting
from the replacement of HSV-1 gD residues with BV gD ones
HSV-1 gD mutant ΔΔG (kcal mol−1)
Position Substitution
4 Leu→ Pro 0.004
5 Ala→ Val −0.495
6 Asp→ Glu −0.044
7 Ala→ Arg −0.631
10 Lys→ Thr 1.591
11 Met→ Arg 1.751
12 Ala→ Val 1.016
13 Asp→ Asn 0.245
15 Asn→ Gly 0.909
20 Lys→ Ala 0.051
21 Asp→ His 0.081
23 Pro→ Ala 0.713
24 Val→ Pro 0.204
26 Asp→ Glu −0.230
28 Leu→ Lys 0.219
total 5.387
Li et al. Theoretical Biology and Medical Modelling 2014, 11:27 Page 12 of 16
http://www.tbiomed.com/content/11/1/27Up to now, the information about the sequence and structural requirements of the BV gD
interaction with its fusion receptor is lacking because there is no structural data on either
BV gD or the BV gD-nectin-1 complex available. In order to investigate how BV gD inter-
acts with its receptor, the 3D structure of the BV gD ECD was constructed using hom-
ology modelling. Homology modelling, also referred to as comparative modelling, is
currently the most accurate computational method for protein structure prediction. A
limitation of homology modelling is that the quality of the predicted model strongly de-
pends on the sequence identity between the target and the template.
The predicted BV gD-nectin-1 model showed that the interface between the BV gD and
the receptor molecule was not geometrically complementary. The detailed analysis of the
interactions between BV gD and nectin-1 suggested that hydrophobic contacts between
these two molecules play key roles in their recognition and binding. Residues within the
N- and C-terminal extensions of BV gD provided more interactions with nectin-1.
The constructed BV gD-HVEM complex model provided a structural basis for the
reason why HVEM does not functions as a receptor for BV. In our observations, the
BV gD-HVEM complex had a lower shape complementarity factor and a smaller inter-
face area compared with the HSV-1 gD-HVEM complex and provided fewer intermo-
lecular interactions. Binding energy calculations mutant HSV-1 gD-HVEM complexes
showed that most mutants from HSV-1 gD residues to BV gD ones are likely to reduce
the binding affinity of HSV-1 gD HVEM interaction. These results could explain why
HVEM does not mediate BV fusion and entry process.
In this study, a modelling approach was successfully applied to generate the struc-
tures of BV gD and its receptors. The predicted complex model provides us with fea-
tures that are consistent with the experimental data and can be considered a rough
approximation of how BV gD might interact with its receptor. Finally, these results
open new avenues for the computer-aided design of potential inhibitors or antagonists
for blocking BV entry and infection.Conclusion
By applying molecular modelling and protein docking methods, three-dimensional
structures of two BV gD-receptor complexes were built. With these structures, we ob-
tained useful information about the detailed interaction between BV gD and its recep-
tors. These models provide a glimpse of a receptor-ligand interaction that can lead to
membrane fusion mediated by herpes B virus.Methods
Data sets
Sequences of BV-gD and HSV-1 gD in FASTA format were retrieved from the public data-
base UniProt/ExPASy (Swiss Bioinformatics Resource) http://expasy.org/tools/ [41], having
accession numbers of Q8UYF8 and Q05059 respectively. The sequence for Cercopithecus
nectin-1 was retrieved from the GenBank data base with the accession number AF308635.Molecular modelling
Searches for reference proteins, sequence alignments and homology modelling were
performed in Discovery Studio 2.5 (Accelrys Inc.). A BLAST search of the PDB
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the BV-gD. The full-length sequence identity between the BV-gD and the templates is
relatively high (62%), the presence of high sequence conservation between the target
and templates suggests that the comparative homology modelling of the BV-gD using
the HSV-1 gD structure as template was appropriate.
To explore the molecular basis for the binding modes of BV-gD to receptor, its struc-
ture should be constructed in “receptor-bound form”. In this paper, structure of HSV-1
gD in complex with receptor were selected for the templates for homology modeling. The
final templates selected for homology modeling were the HSV-1 gD crystal structure in
nectin-1 binding form (PDB code 3U82) and HVEM binding form (PDB code 1JMA).
The quality of the predicted structure was evaluated using the Verify Protein (Profiles-
3D) protocol and Ramachandran Plot.
Profiles-3D Verify checks the validity of a protein structure by measuring the com-
patibility score of each residue in the given 3D environment. Scores for each residue
and the whole protein are reported, and the expected high and low scores for a protein
of the same size are given as a reference point [25].
The Ramachandran Plot indicates low energy conformations for φ and ψ, the conven-
tional terms used to represent the torsion angles on either side of alpha carbons in pep-
tides. This plot often serves as an important check to verify torsion angles in proteins.
The Ramachandran Plot provides a graphical representation of the local backbone con-
formation of each residue in a protein. Each point on the Ramachandran Plot repre-
sents the φ and ψ torsion angles of a residue in protein. The plot also includes a
representation of the allowed and disallowed regions for all residues. According to the
plot, one can determine if individual residues are probably to be built correctly. The
Ramachandran plot computed in here is as updated by Richardson and coworkers [26].Complex structure construction
Structural superposition is the fastest and easiest method for docking a ligand into an
active site [42]. A number of studies have constructed complex models by the super-
position approach [42-47]. Based on the fact that the gD of alphaherpesvirus subfamily
binds to the same entry receptor in a similar fashion at a common site, we prepared
the BV-gD-receptor model by structural superimposition using crystal structure of
HSV-1 gD –nectin-1 complex as template. The putative binding site in BV gD and the
known receptor binding site in HSV-1 gD were superimposed. The BV-gD-receptor
structure was obtained by superposition of the structure of BV-gD onto the structure
of HSV-1 gD in complex with nectin-1, and after removal of the template HSV-1 gD.Protein–protein interaction analysis
The interface area of a complex is derived from its atomic coordinates by computing
its accessible surface area in solvent and subtracting it from the sum of the accessible
surface areas of the isolated components [48]. Accessible surface areas were evaluated
with the program SURVOL [49], which implements the Lee and Richards algorithm
[50]. Group radii were from ref [51], and the radius of the water probe was 1.4 Å.
The shape complementarity (SC) value is used to check how well two adjacent sur-
faces fit together by taking into account distances and angles between both surfaces
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software package (Collaborative Computational Project Number 4 1994).
A hydrophobic contact is defined as a distance between carbon atoms shorter than
4.0 Å [53]. All intermolecular hydrophobic contacts are listed.
Protein structure illustrations were generated with the PyMOL Molecular Graphics
Software [54].Interaction free energy estimation
The binding affinity of a complex is strongly correlated to its relative binding free en-
ergy. To compare the relative binding affinities of the gD-receptor complexes, we cal-
culated the relative binding free energies for these complexes using the FoldX program
[55,56,57]. FoldX uses a full atomic description of the structure of the proteins. The dif-
ferent energy terms taken into account in FoldX have been weighted using empirical
data obtained from protein engineering experiments. The FoldX energy function in-
cludes terms that have been found to be important for protein stability.
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